Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation ...
BioAtla, Inc. (NASDAQ: BCAB or the "Company"), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic ...
Researchers from the National University of Singapore (NUS) have developed CellScope, a high-performance single-cell analysis ...
Allergy research has historically relied on traditional systems such as 2D cell cultures and mouse models to uncover mechanisms underlying allergic ...
Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict the success of different treatments. But cells are complex and contain many ...
With increasing cyberattacks and government data breaches, one of the most important devices to keep secure is the one in ...
Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...
Scientists show that neutralizing liver-derived ApoE protein reverses age-related delays in bone fracture healing ...
Carfilzomib prevented BCMA degradation, increased target density, and improved CAR T susceptibility by ~26%–28% in vitro, while enhancing xenograft antitumor activity without worsening T-cell ...
Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are called codons, and they are the genetic code’s way of spelling out amino ...
UNSW researchers have developed an intrinsic-adjusted single-diode model that explicitly accounts for radiative and Auger recombination, improving I–V curve accuracy and reducing root mean square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results